For the first time, this imaging tracer will be used in an attempt to detect neuroinflammation in the living brain in the setting of Parkinson’s and Alzheimer’s diseases.
Learn why this distinguished clinician-researcher expects to accomplish in one year here what would have taken 10 years at another institution.
Will we fight neurodegenerative diseases the way we robustly took on HIV/AIDS — or with the limited attention we’ve devoted to combating malaria?
A large NIH grant has helped form the first national research consortium for this common neurodegenerative dementia. The search for biomarkers is high on its to-do list.